Egiziano, G;
Widdifield, J;
Rahman, A;
Vinet, E;
Moura, CS;
Curtis, JR;
Bernatsky, S;
(2020)
Antiphospholipid Antibody Testing in a General Population Sample from the USA: An Administrative Database Study.
Scientific Reports
, 10
(1)
, Article 3102. 10.1038/s41598-020-59990-5.
Preview |
Text
Antiphospholipid Antibody Testing in a General Population Sample from the USA An Administrative Database Study.pdf - Published Version Download (837kB) | Preview |
Abstract
We sought to characterized patterns of aPL testing in a large general population sample from the United States. Using Truven Health MarketScan laboratory data from 2010-2015 we identified individuals tested for lupus anticoagulant(LA), anti-cardiolipin (aCL), and anti-beta2-glycoprotein1(aGP1). Our research was approved by the McGill institutional review board (A04-M47-12B). We identified 33,456 individuals with at least one aPL test. Among these, only 6,391 (19%) had all three tests (LA, aCL, aGP1) performed. Confirmatory aPL testing was performed at least 12 weeks later in 77%, 45%, and 41% of initially positive LA, aCL, and aGP1, respectively. Of those re-tested after ≥12 weeks, only 255 (10.6%) were found to have a confirmatory positive aPL test. These findings highlight that aPL testing may often be incompletely performed. Further investigations will be required to better understand the low rate of a confirmatory positive aPL test ≥12 weeks after the initial test.
| Type: | Article |
|---|---|
| Title: | Antiphospholipid Antibody Testing in a General Population Sample from the USA: An Administrative Database Study |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/s41598-020-59990-5 |
| Publisher version: | https://doi.org/10.1038/s41598-020-59990-5 |
| Language: | English |
| Additional information: | © The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). |
| Keywords: | Risk factors, Systemic lupus erythematosus |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10093449 |
Archive Staff Only
 |
View Item |
